bibenzyls - CISMeF

Preferred Label : bibenzyls;

MeSH definition : Compounds with 1,2-diphenylethane. They are structurally like reduced STILBENES.; Compounds that include 1,2-diphenylethane in their structure.;

MeSH synonym : Bisbenzyls; 1,2-Diphenylethane Compounds; 1,2 Diphenylethane Compounds; Compounds, 1,2-Diphenylethane; Dihydrostilbene Compounds; Compounds, Dihydrostilbene;

Is substance : O;

Détails

Origin ID

D001632;

UMLS CUI

C0005352;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- bibenzyls [MeSH concept]
Related MeSH Supplementary Concept(s)
- (Z)-2-(4'-methoxy-3'-aminophenyl)-1-(3,4,5-trifluorophenyl)ethene [MeSH Supplementary Concept]
- 14-hydroxylunularin [MeSH Supplementary Concept]
- 2,4,6-trichloro-3-hydroxybibenzyl [MeSH Supplementary Concept]
- 2,4-dichloro-3-hydroxybibenzyl [MeSH Supplementary Concept]
- 2-(2-(4-heptylphenyl)ethyl)-6-hydroxy-benzoic acid [MeSH Supplementary Concept]
- 2-(3-methyl-2-butenyl)-3,5,4'-trihydroxy-bibenzyl [MeSH Supplementary Concept]
- 2-chloro-3-hydroxybibenzyl [MeSH Supplementary Concept]
- 3,3',4,5'-tetrahydroxybibenzyl [MeSH Supplementary Concept]
- 3,4'-dihydroxy-5,5'-dimethoxybibenzyl [MeSH Supplementary Concept]
- 4,4'-diaminodibenzyl [MeSH Supplementary Concept]
- 4,4'-dihydroxy-3,3',5,alpha-tetramethoxybibenzyl [MeSH Supplementary Concept]
- 4,4'-dihydroxybibenzyl [MeSH Supplementary Concept]
- 4,5-dihydroxy-3,3',alpha-trimethoxybibenzyl [MeSH Supplementary Concept]
- 4,6-dimethoxy-9-(4-methoxybenzyl)-8-(2-(4-methoxyphenyl)ethyl)-9H-xanthene-2,3,5-triol [MeSH Supplementary Concept]
- 4-(3-bibenzyl-4-yl-propyl)morpholine [MeSH Supplementary Concept]
- 4-acetoxy-3,5,3',4'-tetramethoxybibenzyl [MeSH Supplementary Concept]
- 4-dimethylaminobibenzyl [MeSH Supplementary Concept]
- 4-hydroxy-3'-methoxybibenzyl [MeSH Supplementary Concept]
- 4-hydroxy-3,3',4',5,alpha-pentamethoxybibenzyl [MeSH Supplementary Concept]
- 4-nitrosobibenzyl [MeSH Supplementary Concept]
- 5-fluoro-2,3-bis(4-hydroxyphenyl)pentanenitrile [MeSH Supplementary Concept]
- 5-hydroxy-4-(4-hydroxybenzyl)-3',3-dimethoxybibenzyl [MeSH Supplementary Concept]
- bibenzyl xyloside [MeSH Supplementary Concept]
- bletillin A [MeSH Supplementary Concept]
- bletillin B [MeSH Supplementary Concept]
- bulbotetusine [MeSH Supplementary Concept]
- canniprene [MeSH Supplementary Concept]
- cderiv [MeSH Supplementary Concept]
- chrysotoxine [MeSH Supplementary Concept]
- combretastatin [MeSH Supplementary Concept]
- combretastatin B-3 [MeSH Supplementary Concept]
- combretastatin B-4 [MeSH Supplementary Concept]
- dencryol A [MeSH Supplementary Concept]
- dencryol B [MeSH Supplementary Concept]
- dendrocandin C [MeSH Supplementary Concept]
- dendrocandin D [MeSH Supplementary Concept]
- dendrocandin E [MeSH Supplementary Concept]
- dendrocandin T [MeSH Supplementary Concept]
- dendrocandin U [MeSH Supplementary Concept]
- erianin [MeSH Supplementary Concept]
- erythro-alpha-ethyl-alpha'-methyl-4,4'-dihydroxybibenzyl [MeSH Supplementary Concept]
- gigantol [MeSH Supplementary Concept]
- glepidotin A [MeSH Supplementary Concept]
- glepidotin B [MeSH Supplementary Concept]
- heudelotol A [MeSH Supplementary Concept]
- heudelotol B [MeSH Supplementary Concept]
- kurzphenol A [MeSH Supplementary Concept]
- laureliopsine A [MeSH Supplementary Concept]
- lunularin [MeSH Supplementary Concept]
- lunularin-4-O-beta-D-glucoside [MeSH Supplementary Concept]
- marchantin A [MeSH Supplementary Concept]
- marchantin A trimethyl ether [MeSH Supplementary Concept]
- marchantin C [MeSH Supplementary Concept]
- marchantin H [MeSH Supplementary Concept]
- marchantin M [MeSH Supplementary Concept]
- marchantin O [MeSH Supplementary Concept]
- marchantin P [MeSH Supplementary Concept]
- marchantinquinone [MeSH Supplementary Concept]
- nobilin D [MeSH Supplementary Concept]
- nobilin E [MeSH Supplementary Concept]
- pakyonol [MeSH Supplementary Concept]
- preracemosol A [MeSH Supplementary Concept]
- preracemosol B [MeSH Supplementary Concept]
- racemosol [MeSH Supplementary Concept]
- riccardin F [MeSH Supplementary Concept]
- sanionin A [MeSH Supplementary Concept]
- stilbostemin B 3'-beta-D-glucopyranoside [MeSH Supplementary Concept]
- stilbostemin H 3'-beta-D-glucopyranoside [MeSH Supplementary Concept]
- stilbostemin I 2''-beta-D-glucopyranoside [MeSH Supplementary Concept]
- trigonopol A [MeSH Supplementary Concept]
- trigonopol B [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients